Summary of Significant Accounting Policies - Additional Information (Detail) (USD $)
|
0 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | 0 Months Ended | 9 Months Ended | 0 Months Ended | 9 Months Ended | 0 Months Ended | 12 Months Ended | 9 Months Ended | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 22, 2014
|
Sep. 30, 2014
Segment
|
Sep. 30, 2013
Segment
|
Sep. 30, 2014
Segment
|
Sep. 30, 2013
Segment
|
Dec. 31, 2013
|
Aug. 20, 2014
|
Dec. 31, 2012
|
Sep. 30, 2014
Level 1
|
Dec. 31, 2013
Level 1
|
Jun. 30, 2014
Series G Redeemable Convertible Preferred Stock
|
Jun. 30, 2014
Series G Preferred Stock
|
Sep. 30, 2014
Series G Preferred Stock
|
Sep. 30, 2013
Series G Preferred Stock
|
Apr. 22, 2014
Incentive Stock Options
Employees
|
Apr. 22, 2014
Nonqualified Stock Options
Consultants
|
Sep. 30, 2014
Tranche C Term Loan
|
Sep. 30, 2014
Tranche B loan
|
Sep. 30, 2014
New consolidated note
|
Jun. 30, 2014
Notes Payable One
Series G Redeemable Convertible Preferred Stock
|
Sep. 30, 2014
Value Lighting
|
Dec. 31, 2013
Issuance of Equity
|
Sep. 30, 2014
Minimum
|
Sep. 30, 2014
Maximum
|
|
Summary Of Significant Accounting Policies [Line Items] | ||||||||||||||||||||||||
Number of reportable segments | 2 | 2 | 2 | 2 | ||||||||||||||||||||
Cash and cash equivalents | $ 2,398,000 | $ 5,763,000 | $ 2,398,000 | $ 5,763,000 | $ 1,757,000 | $ 4,434,000 | ||||||||||||||||||
Cash flow from operations | (15,697,000) | (5,214,000) | ||||||||||||||||||||||
Cash paid for acquisition related costs | 900,000 | 3,300,000 | 3,600,000 | |||||||||||||||||||||
Cash flow from operations | 8,100,000 | |||||||||||||||||||||||
Working capital excluding cash and cash equivalent | 16,300,000 | 16,300,000 | (1,800,000) | |||||||||||||||||||||
Cash proceeds from issuance of convertible preferred stock | 10,000,000 | |||||||||||||||||||||||
Cash proceeds from issuance of common stock | 4,948,000 | 5,000,000 | ||||||||||||||||||||||
Cash borrowed under a receivable financing facility | 900,000 | |||||||||||||||||||||||
Proceeds from related party debt | 18,103,000 | 18,600,000 | 10,800,000 | |||||||||||||||||||||
Stock issued in noncash exchange | 18,000,000 | |||||||||||||||||||||||
Debt exchanged with stock, amount | 12,600,000 | 12,600,000 | 12,600,000 | |||||||||||||||||||||
Accrued dividend settled in stock | 5,400,000 | |||||||||||||||||||||||
Debt exchange with new consolidated note | 5,700,000 | |||||||||||||||||||||||
Debt conversion,interest rate | 9.00% | |||||||||||||||||||||||
Debt conversion due date | Apr. 01, 2016 | |||||||||||||||||||||||
Debt instrument amount | 2,700,000 | 2,700,000 | 2,600,000 | |||||||||||||||||||||
Line of credit facility, maximum borrowing amount | 25,000,000 | |||||||||||||||||||||||
Unamortized licensing fees Period | 3 years | 10 years | ||||||||||||||||||||||
Sales tax include in revenue | 944,000 | 22,000 | 1,547,000 | 544,000 | ||||||||||||||||||||
Cash equivalents at fair value | 2,398,000 | 1,757,000 | ||||||||||||||||||||||
Maturity of temporary cash investments | 3 months | |||||||||||||||||||||||
Net deferred tax liabilities | $ 5,600,000 | |||||||||||||||||||||||
Stock options granted | 52,500 | 0 | 52,500 | 35,000 | 17,500 | |||||||||||||||||||
Stock options strike price | $ 3.02 | $ 2.32 | ||||||||||||||||||||||
Stock options vesting period | 3 years | |||||||||||||||||||||||
Stock options vesting period beginning date | Apr. 22, 2015 | |||||||||||||||||||||||
Stock options expiration period | 10 years | |||||||||||||||||||||||
Anti-dilutive shares | 27,200,000 | 23,000,000 | 27,200,000 | 23,000,000 |